Clinical Trial Update: Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating frailty-adjusted therapy for transplant non-eligible patients with newly diagnosed multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University of Leeds | Conditions: Multiple Myeloma | Phase 3 | Status: UNKNOWN